The Fund enables the private sector to responsibly share benefits from the commercial use of Digital Sequence Information on genetic resources (DSI) back to the developing countries and indigenous peoples and local communities who steward biodiversity.
Through the Fund, large companies such as pharmaceuticals, nutraceuticals cosmetics, and biotechnology contribute through a simple and predictable model - either 0.1% of annual revenue or 1% of annual profit.
